Fly News Breaks for April 19, 2017
INCY
Apr 19, 2017 | 07:53 EDT
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $167 from $174 on Baricitinib's surprise CRL. The analyst moved baricitinib's U.S. launch to 2019 and lowered the probability of success on U.S. revenues to 80%. Young reiterates an Outperform rating on the shares.
News For INCY From the Last 2 Days